Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia Region: A report from the Pediatric Oncology East and Mediterranean (POEM) Group
Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia Region: A report from the Pediatric Oncology East and Mediterranean (POEM) Group
复制标题
DOI：
10.1002/cncr.33075
复制
发表时间：
2020-07-10
期刊：
影响因子：
6.2
通讯作者：
Jeha, Sima
中科院分区：
文献类型：
--
作者：
Saab, Raya;Obeid, Anas;Jeha, Sima
背景儿童癌症是一种高度可治愈的疾病，如果提供及时的诊断和适当的治疗。2019冠状病毒病（COVID-19）大流行可能对癌症儿童获得护理产生负面影响，但尚未进行评估。方法：将一项34项调查分发给中东、北非和西亚地区的儿科肿瘤学东部和地中海（POEM）协作组儿科肿瘤科负责人，重点关注COVID-19大流行期间儿科肿瘤学管理的障碍。回复于2020年4月11日至22日收集。已证实的COVID-19病例和死亡的相应比率从世界卫生组织数据库中检索。结果共有来自19个国家的34个中心参与。几乎所有中心都采用了指导方针来优化资源利用和安全性，包括推迟停止治疗的访问，轮换和减少工作人员，以及实施社交距离，手部卫生措施和个人防护设备的使用。包括化疗、手术和放疗在内的基本治疗在29%至44%的中心被推迟，24%的中心限制接受新患者。据报道，28%的中心的临床护理服务受到负面影响。超过70%的中心报告血液制品短缺，47%至62%的中心报告手术和放射治疗中断以及药物短缺。然而，床位供应受到影响，
Background Childhood cancer is a highly curable disease when timely diagnosis and appropriate therapy are provided. A negative impact of the coronavirus disease 2019 (COVID-19) pandemic on access to care for children with cancer is likely but has not been evaluated. METHODS A 34-item survey focusing on barriers to pediatric oncology management during the COVID-19 pandemic was distributed to heads of pediatric oncology units within the Pediatric Oncology East and Mediterranean (POEM) collaborative group, from the Middle East, North Africa, and West Asia. Responses were collected on April 11 through 22, 2020. Corresponding rates of proven COVID-19 cases and deaths were retrieved from the World Health Organization database. Results In total, 34 centers from 19 countries participated. Almost all centers applied guidelines to optimize resource utilization and safety, including delaying off-treatment visits, rotating and reducing staff, and implementing social distancing, hand hygiene measures, and personal protective equipment use. Essential treatments, including chemotherapy, surgery, and radiation therapy, were delayed in 29% to 44% of centers, and 24% of centers restricted acceptance of new patients. Clinical care delivery was reported as negatively affected in 28% of centers. Greater than 70% of centers reported shortages in blood products, and 47% to 62% reported interruptions in surgery and radiation as well as medication shortages. However, bed availability was affected in